Analyst Ratings for Cue Biopharma (CUE)

CUE Rating Summary

CUE Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CUE
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $30.40 (+178.9%) * Over Last 12-Mos
Rating Score: 10 / 10   Percentile Rank: 95%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
11/24/2020 Berenberg Zhiqiang Shu New Coverage Buy
(N/A)
30.00
(N/A)
12.01
(10.90)
-9.24% Details
4/9/2020 Stifel
» Updated 11/18/2020
Stephan Willey New Coverage Buy
(N/A)
27.00
(30.00)
15.07
(10.90)
-27.67% Details